A deletion polymorphism in the RIZ gene is associated with increased progression of imatinib treated chronic myeloid leukemia patients. [electronic resource]
Producer: 20180112Description: 1694-1701 p. digitalISSN:- 1029-2403
- Adult
- Aged
- Alleles
- Case-Control Studies
- DNA-Binding Proteins -- genetics
- Disease Progression
- Female
- Fusion Proteins, bcr-abl -- genetics
- Genotype
- Histone-Lysine N-Methyltransferase -- genetics
- Humans
- INDEL Mutation
- Imatinib Mesylate -- administration & dosage
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Middle Aged
- Neoplasm Staging
- Nuclear Proteins -- genetics
- Polymorphism, Genetic
- Sequence Deletion
- Transcription Factors -- genetics
- Translocation, Genetic
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.